Aguilar RF, López GA

Language: Spanish
References: 14
Page: 89-95
PDF size: 429.42 Kb.

ABSTRACT

Introduction: Since December 2019 there has been a dizzying spread of what we now know as coronavirus disease SARS-CoV-2 or COVID-19, named for the world health organization (WHO) in March 2020. Objective: Report the neurological manifestations of COVID-19. Results: Initially, the symptoms were mainly respiratory, however, neurological signs and symptoms associated with this virus have been increasingly evident, such as headache, nausea, vomiting, encephalopathy, encephalitis, cerebrovascular disease, anosmia, ageusia, seizures, cranial nerve alteration, peripheral neuropathy, Guillain-Barre syndrome, neuromuscular amyotrophy and rhabdomyolysis. The mechanisms of neurological involvement of COVID-19 are attributed to two types of invasion; direct (due to the neurotropic properties of the virus) and indirect invasion (derived from the pro-inflammatory and procoagulant state, metabolic alterations and dysregulation of the immune system). Conclusions: Despite the incidence of these neurological complications, the increase in morbidity and mortality will allow us to make timely decisions that impact the prevention of the neurological morbidity and mortality process in patients with COVID-19.

REFERENCES

1. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: a systematic review. J Neurol Sci. 2020; 413: 1-4.

2. Reporte del día 14 de Julio de 2021 de los casos activos, sospechosos y la población fallecida en México. Secretaría de Salud 2021.

3. Hamid S, Mir MY, Rohela GK. Novel coronavirus disease (COVID-19): a pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes New Infect. 2020; 35: 100679. doi: 10.1016/j.nmni.2020.100679.

4. Matías-Guiu UJ, Gomez-Pinedo P, Montero-Escribano P, Gomez-Iglesias J, Porta-Etessam J, Matias-Guiu A. ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2? Neurología. 2020; 35: 170-175. doi: 10.1016/j.nrl.2020.03.001.

5. Filatov A, Sharma P, Hindi F, Espinosa SP. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020; (3): e7352. doi: 10.7759/cureus.7352.

6. Poyiadji N, Shahin G, Noujaim D, Stone M, Patel, Brent GS. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020; 296: 1527-1315. doi: org/10.1148/radiol.2020201187.

7. Salas AJ, Sánchez GC, Rodríguez SR. Características clínicas y comorbilidades asociadas a mortalidad en pacientes con COVID-19 en Coahuila (México). Revista Clínica Española. 2020; 3: 151-157.

8. Von Oertzen TJ. COVID-19-neurologists stay aware! Eur J Neurol. 2020; 27: 14-36.

9. Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P et al. Guillain-Barré syndrome related to COVID-19 infection. Neuroinflamm. 2020; 7 (4): e741. doi: org/10.1212/NXI.000000000000074.

10. Hess DC, Eldahsahn W, Rutkowski E. COVID-19-related stroke. Transl Stroke Res. 2020; 7: 1-4.

11. Camelo-Filho AE, Silva AMS, Estephan EP, Zambon AA, Mendonca RH, Souza PVS et al. Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Front Neurol. 2020; 11: 1053. doi: org/10.3389/fneur.2020.01053.

12. Dinkin M, Gao V, Kahan J, Bobker S, Simonetto M, Wechsler P et al. COVID-19 presenting with ophthalmoparesis from cranial nerve palsy. Neurology. 2020; 95 (5): 221-223. doi: https://doi.org/10.1212/WNL.0000000000009700

13. Rubin R. As their numbers grow, COVID-19 "long haulers" stump experts. JAMA. 2020; 324 (14): 1381-1383. doi: org/10.1007/s12975-020-00818-9.

14. Abdelnour L, Abdalla ME, Babiker S. COVID-19 infection presenting as motor peripheral neuropathy. J Formos Med Assoc. 2020; 119 (6): 1119-1120. doi: 10.1016/j.jfma.2020.04.024.